Transplanted stem cell-secreted VEGF effects post-stroke recovery, inflammation, and vascular repair
نویسندگان
چکیده
Cell transplantation offers a novel therapeutic strategy for stroke; however, how transplanted cells function in vivo is poorly understood. We show for the first time that after sub-acute transplantation into the ischemic brain of human central nervous system stem cells grown as neurospheres (hCNS-SCns), the stem cell-secreted factor, human VEGF (hVEGF), is necessary for cell-induced functional recovery. We correlate this functional recovery to hVEGF-induced effects on the host brain including multiple facets of vascular repair, and its unexpected suppression of the inflammatory response. We found that transplanted hCNS-SCns affected multiple parameters in the brain with different kinetics: early improvement in blood-brain barrier (BBB) integrity and suppression of inflammation was followed by a delayed spatio-temporal regulated increase in neovascularization. These events coincided with a bi-modal pattern of functional recovery: an early recovery independent of neovascularization, and a delayed hVEGFdependent recovery coincident with neovascularization. Therefore, cell transplantation therapy Correspondence and requests for reprints to: Tonya Bliss, PhD, [email protected], Dept Neurosurgery, 1201 Welch Rd, Stanford, CA 94305-5487, USA, Tel: +1 650 723 2004, Fax: +1 650 736 1949 or Gary K. Steinberg, MD, PhD, [email protected], Dept Neurosurgery, 1201 Welch Rd, Stanford, CA 94305-5487, USA, Tel: +1 650 725 5562, Fax: +1 650 723 2815. *These authors contributed equally to this work **Co-senior authors Nobutaka Horie has moved to the Department of Neurosurgery, Nagasaki University School of Medicine, 1-7-1, Sakamoto, Nagasaki, Japan, 852-8501 Disclosure of Potential Conflicts of Interest: S.H. is a full time employee of StemCells Inc, the company that provided the cells, and has equity (stock) in the company. The other authors have no financial interests to disclose. Author Contributions: Nobutaka Horie: Design, collection and assembly of data, data analysis and interpretation, manuscript writing Kuniyasu Niizuma: Collection and assembly of data, data analysis and interpretation Marta P. Pereira: Design, collection and assembly of data, data analysis and interpretation, manuscript writing Guohua Sun: Collection of data Hadar Keren-Gill: Collection of data Angelo Encarnacion: Collection of data Mehrdad Shamloo: Collection of data Scott A. Hamilton: Statistical analysis advice Kewen Jiang: Collection of data Stephen Huhn: Provision of study material, manuscript writing Theo D. Palmer: Data analysis and interpretation Tonya M. Bliss: Conception and design, data analysis and interpretation, manuscript writing, final approval of manuscript Gary K. Steinberg: Financial support, design, data interpretation, manuscript writing, final approval of manuscript NIH Public Access Author Manuscript Stem Cells. Author manuscript; available in PMC 2012 December 18. Published in final edited form as: Stem Cells. 2011 February ; 29(2): . doi:10.1002/stem.584. N IH PA Athor M anscript N IH PA Athor M anscript N IH PA Athor M anscript offers an exciting multi-modal strategy for brain repair in stroke and potentially other disorders with a vascular or inflammatory component.
منابع مشابه
Therapeutic angiogenesis promotes efficacy of human umbilical cord matrix stem cell transplantation in cardiac repair
Objective(s):Although previous studies have confirmed the beneficial effects of human umbilical cord matrix stem cell (hUCM) transplantation post myocardial infarction (MI), but this stem cell resource has no potential to induce angiogenesis. In order to achieve the process of angiogenesis and cardiomyocyte regeneration, two required factors for cardiac repair agents were examined namely; hUCM ...
متن کاملCo-Transplantation of VEGF-Expressing Human Embryonic Stem Cell Derived Mesenchymal Stem Cells to Enhance Islet Revascularization in Diabetic Nude Mice
Background: Pancreatic islet transplantation has emerged as a promising treatment for type I diabetes. However, its efficacy is severely hampered due to poor islet engraftment and revascularization, which have been resulted to partially loss of transplanted islets. It has been shown that local delivery of vascular endothelial growth factor (VEGF) could accelerate transplanted islet revasculari...
متن کاملVasculogenesis in experimental stroke after human cerebral endothelial cell transplantation.
BACKGROUND AND PURPOSE Despite the reported functional recovery in transplanted stroke models and patients, the mechanism of action underlying stem cell therapy remains not well understood. Here, we examined the role of stem cell-mediated vascular repair in stroke. METHODS Adult rats were exposed to transient occlusion of the middle cerebral artery and 3 hours later randomly stereotaxically t...
متن کاملHuman Neural Stem Cells Over-Expressing VEGF Provide Neuroprotection, Angiogenesis and Functional Recovery in Mouse Stroke Model
BACKGROUND Intracerebral hemorrhage (ICH) is a lethal stroke type. As mortality approaches 50%, and current medical therapy against ICH shows only limited effectiveness, an alternative approach is required, such as stem cell-based cell therapy. Previously we have shown that intravenously transplanted human neural stem cells (NSCs) selectively migrate to the brain and induce behavioral recovery ...
متن کاملVascular Endothelial Growth Factor from Embryonic Status to Cardiovascular Pathology
Vascular endothelial growth factor (VEGF) is a multifunctional cytokine with distinct functions in angiogenesis, lymphangiogenesis, vascular permeability, and hematopoiesis. VEGF is a highly conserved, disulfide-bonded dimeric glycoprotein of 34 to 45 kDa produced by several cell types including fibroblasts, neutrophils, endothelial cells, and peripheral blood mononuclear cells, particularly T ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013